ArticleOncotarget2020
A mutation-specific, single-arm, phase 2 study of dovitinib in patients with advanced malignancies.
Matthew H Taylor et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it
ArticleOncotarget2020
Matthew H Taylor et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.